CoChat

Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy

Open access
Oshima, Nobu, Ishida, Ryo, Kishimoto, Shun, Beebe, Kristin, Brender, Jeffrey R., Yamamoto, Kazutoshi, Urban, Daniel, Rai, Ganesha, Johnson, Michelle S., Benavides, Gloria, Squadrito, Giuseppe L., Crooks, Dan, Jackson, Joseph, Joshi, Abhinav, Mott, Bryan T., Shrimp, Jonathan H., Moses, Michael A., Lee, Min-Jung, Yuno, Akira, Lee, Tobie D., Hu, Xin, Anderson, Tamara, Kusewitt, Donna, Hathaway, Helen H., Jadhav, Ajit, Picard, Didier, Trepel, Jane B., Mitchell, James B., Stott, Gordon M., Moore, William, Simeonov, Anton, Sklar, Larry A., Norenberg, Jeffrey P., Linehan, W. Marston, Maloney, David J., Dang, Chi V., Waterson, Alex G., Hall, Matthew, Darley-Usmar, Victor M., Krishna, Murali C., Neckers, Leonard M. · 2020 · Cell Reports
Cited by 125

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

The reliance of many cancers on aerobic glycolysis has stimulated substantial efforts to develop inhibitors of enzymes in this pathway, including lactate dehydrogenase (LDH). However, despite significant efforts, there have been no reports to date of an LDH inhibitor (LDHi) with sufficient specificity and in vivo activity to determine whether LDH is a feasible drug target and if LDH inhibition alone will suppress growth of glycolytic tumors. Here we describe an LDHi with potent, on-target in vivo activity that has allowed us to address these questions. Using hyperpolarized magnetic resonance spectroscopic imaging (HP-MRSI) of [13C]pyruvate metabolism, we demonstrate dynamic in vivo LDH inhibition in two glycolytic cancer models, MIA PaCa-2 and HT29, and we correlate LDH inhibition with direct anti-tumor activity. However, HP-MRSI also reveals a metabolic rewiring that occurs within 30 min of LDH inhibition in vivo, wherein pyruvate flux in tumor xenografts is redirected toward mitochondrial metabolism, consistent with perturbation of the NADH/NAD+ redox couple. HP-MRSI also shows that in vivo inhibition of mitochondrial complex 1 inhibition rapidly redirects tumor pyruvate flux toward lactate and, importantly, inhibition of both mitochondrial complex 1 and LDH suppresses metabolic plasticity and drives these cancer cells into metabolic quiescence in vivo while causeing tumor stasis in vivo. These data highlight the importance of pyruvate flux in tumor metabolic plasticity in vivo, even in glycolytic models, and they demonstrate the utility of HP-MRSI in monitoring drug-dependent changes in tumor metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2020.01.039

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 125

Metadata

Authors
Oshima, N., Ishida, R., Kishimoto, S., Beebe, K., Brender, J. R., Yamamoto, K., Urban, D., Rai, G., Johnson, M. S., Benavides, G., Squadrito, G. L., Crooks, D., Jackson, J., Joshi, A., Mott, B. T., Shrimp, J. H., Moses, M. A., Lee, M.-J., Yuno, A., Lee, T. D., Hu, X., Anderson, T., Kusewitt, D., Hathaway, H. H., Jadhav, A., Picard, D., Trepel, J. B., Mitchell, J. B., Stott, G. M., Moore, W., Simeonov, A., Sklar, L. A., Norenberg, J. P., Linehan, W. M., Maloney, D. J., Dang, C. V., Waterson, A. G., Hall, M., Darley-Usmar, V. M., Krishna, M. C., & Neckers, L. M.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2020-02
Volume
30
Issue
6
Pages
1798-1810.e4
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2979832385
Cited by
125
References
12
FWCI
5.03
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.